Divi's Lab.

64
Hold
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE361B01024
  • NSEID: DIVISLAB
  • BSEID: 532488
INR
6,421.65
-48.95 (-0.76%)
BSENSE

Dec 05

BSE+NSE Vol: 31.12 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Divi's Lab. Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
2,916.00
2,163.00
2,369.00
3,683.00
2,666.00
1,819.00
Adjustment
115.00
81.00
144.00
239.00
189.00
60.00
Changes In working Capital
-554.00
-607.00
419.00
-1,370.00
-264.00
-218.00
Cash Flow after changes in Working Capital
2,477.00
1,637.00
2,932.00
2,552.00
2,591.00
1,661.00
Cash Flow from Operating Activities
1,653.00
1,261.00
2,459.00
1,911.00
1,946.00
1,215.00
Cash Flow from Investing Activities
-804.00
-269.00
-2,707.00
-2,194.00
75.00
-83.00
Cash Flow from Financing Activities
-799.00
-799.00
-797.00
-532.00
-34.00
-1,091.00
Net Cash Inflow / Outflow
50.00
193.00
-1,045.00
-815.00
1,987.00
41.00
Opening Cash & Cash Equivalents
363.00
170.00
1,215.00
2,030.00
43.00
2.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
413.00
363.00
170.00
1,214.00
2,030.00
43.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Divi's Lab.
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
2916
13752.13
-10,836.00
-78.80%
Adjustment
115
1120.36
-1,005.00
-89.74%
Changes In working Capital
-554
-323.56
-231.00
-71.22%
Cash Flow after changes in Working Capital
2477
14548.93
-12,071.00
-82.97%
Cash Flow from Operating Activities
1653
14072.09
-12,419.00
-88.25%
Cash Flow from Investing Activities
-804
-5183.15
4,379.00
84.49%
Cash Flow from Financing Activities
-799
-7905.82
7,106.00
89.89%
Net Cash Inflow / Outflow
50
983.12
-933.00
-94.91%
Opening Cash & Cash Equivalents
363
9285.65
-8,922.00
-96.09%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
413
10268.77
-9,855.00
-95.98%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 31.09% vs -48.72% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
1,653.00
1,261.00
31.09%